Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018–2022

Dorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe · 2026

Read Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018–2022 by Dorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355721.txt.

Description

Dorcas Kalaba and co-authors reviewed outcomes for drug-resistant tuberculosis treatment across Zambia over five years. Success rates sat below the global target, and national evidence on who fares worst was thin. Their 2026 study drew programme records for more than twelve hundred patients treated in all ten provinces.

About two thirds of patients finished with a favourable outcome. Normal body weight more than doubled the odds of success compared with underweight patients. Two provinces, Muchinga and Western, showed markedly lower success odds than the rest. Kalaba and colleagues argue food support and province-targeted fixes are essential if Zambia is to close its resistant-TB outcome gap.

Catalog record

CREATORDorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33427
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0355721

Browse the full library · About the Tower of Babel